Background: The concept of metabolic syndrome (MetS) was initially designed for long-term outcome prediction in middle aged or younger individuals, but it is unclear whether MetS can be applied in older people. We explored the clinical utility of MetS for prediction of various outcomes in older people. First, we investigated whether MetS is associated with CVD and DM in the short term. Second, we took multiple chronic illnesses into consideration to examine whether MetS is associated with increased physical limitations. Conclusions: MetS has short-term (3 years) effects on CVD and DM. After taking chronic illnesses into consideration, no association between MetS and physical functioning was obvious. More studies are needed to clarify the relationship among MetS, chronic illnesses, and physical functioning.
Introduction
The metabolic syndrome (MetS) is generally characterized as a clustering of abnormal blood lipid levels, impaired fasting glucose, elevated blood pressure, and obesity 1 . The term MetS is used to identify people who are at higher risk of cardiovascular disease (CVD) and diabetes mellitus (DM) 2 . Results from cross-sectional studies have shown that MetS prevalence increases dramatically with age 3 . The prevalence ranges from 5.2% in those aged 20e29 years to 36.5% in those aged 70e79 years in Taiwan 4 . These results imply that MetS is an important issue for older populations. However, the concept of MetS was initially designed for long-term prediction of CVD or DM in middle-aged or younger individuals 5 . If this approach was applied to older people, two problems could occur. First, aging per se is associated with increased incidence and prevalence of CVD, DM, and other chronic illnesses. Approximately 70% of older Taiwanese have one or more chronic illnesses, for whom medications and lifestyle changes are primary treatment approaches. For those who already have CVD or DM, there is no further recommendation for additional MetS diagnosis. Thus, the concept of MetS is only applicable to older people without chronic illnesses. Even for elderly individuals without chronic illnesses, owing to their limited life expectancy, use of long-term predictors might not be suitable for this population.
Some researchers have claimed that, in addition to predicting CVD and DM, MetS is associated with a decline in physical functions. For example, obesity, one of the features of MetS, is independently and directly related to mobility and functional declines 6 . 
Methods
The data were taken from The Social Environment and Biomarkers of Aging Study (SEBAS, 2000) 13 and The Survey of 14 . Both SEBAS and TLSA included face-to-face interviews to gather data on demographics, physical functioning, and history of chronic illnesses. SEBAS also included a medical examination and measurement of biomarkers to supplement the interview data. SEBAS was approved by the institutional review board at the National Institute of Family Planning in Taiwan. People aged ! 65 years with blood sample in 2000, history of chronic diseases, and complete data on mobility, activities of daily living (ADL) and instrumental activities of daily living (IADL) were included in this study. Among the SEBAS participants, 559 were ! 65 years and were followed up in TLSA. Of these, 15 were excluded from our study owing to insufficient data (1 for waist circumference in 2000, 7 for mobility in 2000, 1 for ADL in 2000, 5 for IADL in 2000, 2 for mobility in 2003). Thus, 543 older Taiwanese (215 females) were eligible for our study. The average age was 73.9 AE 5.4 years (range 65e98 years).
Metabolic syndrome
The presence of MetS at baseline was assessed according to NCEP ATP-III with modified criteria on waist circumference for Asians 15 . There are five components in the definition: abdominal obesity (waist circumference ! 90 cm in men, ! 80 cm in women), elevated triglycerides (!150 mg/dL), low high-density lipoprotein cholesterol (<40 mg/dL in men, <50 mg/dL in women), elevated blood pressure (systolic blood pressure ! 130 mmHg or diastolic blood pressure ! 85 mmHg, or on antihypertensive drug treatment), and elevated fasting glucose (! 100 mg/dL or on drug treatment for elevated glucose). A diagnosis of MetS is made if at least three criteria are met.
Physical functional indexes
Physical functioning was assessed in terms of mobility, ADL, and IADL. All items were rated on a scale from 0 (no problem) to 3 (cannot perform alone). Mobility was assessed in terms of subjective difficulties in various physical tasks using nine items (e.g., squatting, walking 200e300 m). ADL relates to subjective difficulties in meeting various personal care needs and was assessed using six items (e.g., eating, going to the toilet). IADL relates to subjective difficulties in various activities necessary for maintaining a living environment. It was assessed using six items (e.g., buying personal items, traveling by bus). Composite variables were constructed to create a mobility score (range of 0e27), an ADL score, and an IADL score (range of 0e18 for both). Higher scores correspond to greater limitations in physical functioning.
Self-reported history of chronic illness
Eight out of the 14 conditions listed in the interview questionnaire for history of chronic illnesses were selected from the top 10 leading causes of death in Taiwan: cancer or malignant tumor, stroke (cerebral hemorrhage), CVD, DM, liver or gall bladder disease, kidney disease, and lower respiratory tract disease. The remaining six conditions on the list are likely to cause considerable physical discomfort, including: arthritis or rheumatism, hip fracture, cataracts, gout, and a bone spur.
Results
The MetS prevalence was 40.7% in the cohort. Table 1 Hierarchical regression models of physical functioning are presented in Table 3 
Conclusions
According to our results, MetS cannot be used to predict the incidence of CVD or DM in the short term. The utility of MetS should be more feasible in predicting physical functional decline. However, our results show that MetS was associated with CVD and DM three years after the identification. After considering function-impairing chronic illnesses, we did not find any significant association between MetS and physical functional limitations. Most studies of MetS predicting CVD and DM looked at an interval of more than 10 years. To the best of our knowledge, only one study explored the relationship between MetS and the incidence of CVD and other chronic diseases in the short term, and no correlation between MetS and CVD was found in non-diabetic older people 16 . Since older people without diabetes have relatively healthier lifestyle, the study sample might not be a good representation of the entire older population. The external validity of the study is limited. We used a nationally representative sample and statistically controlled for the presence of chronic illnesses. The results show that MetS is associated with CVD and DM in older Taiwanese individuals. Therefore, MetS in older people is still worthy of attention. Some previous studies have shown an association between MetS and physical functional dependence in older people. However, none of these studies took other function-impairing chronic illnesses into consideration. According to our results, DM has salient effects on physical functioning. Older people with diabetes not only have more limited mobility, but also have more difficulties in self-care. Other chronic illnesses limit only mobility and not self-care abilities. After controlling for chronic illnesses, we found hardly any association between MetS and physical functional limitations. Therefore, in terms of preventing disabilities, the effects of chronic illnesses should be considered more seriously.
Ideally, the use of older people without CVD or DM as a study population could produce more powerful evidence to clarify the association between MetS and CVD or DM. However, only a small proportion of the elderly do not have CVD or DM. In the present study, only 246 (45.3%) participants were without CVD and DM, and among them, only 63 (25.6%) met the MetS criteria. The low sample number and uneven distribution might diminish the power of the findings in this study. Furthermore, older people without CVD or DM might have different lifestyles from those who have CVD or DM. A rigorous sampling strategy would lower the external validity and there would be more limitations in applying the study results. We controlled for the presence of CVD and DM to maintain the representativeness of the sample statistically. The results show that MetS is associated with CVD and DM over a period of 3 years. In other words, if older people meet the MetS criteria, they have a significantly higher chance of developing CVD or DM within 3 years. Therefore, active intervention to prevent CVD and DM is warranted for older people with MetS.
According to our results, MetS has a weak or no association with physical functional limitations after controlling for chronic illnesses. The results do not support a direct correlation between MetS and functional decline in older people. The findings seem to imply that a complex relationship exists among MetS, chronic illnesses, and physical functioning. More research is needed to clarify the association between MetS, chronic illnesses, and functional decline, and to explore the underlying mechanisms.
